Biovica International AB (publ) (STO:BIOVIC.B)

Biovica International AB Statistics

Total Valuation

STO:BIOVIC.B has a market cap or net worth of SEK 122.89 million. The enterprise value is 25.27 million.

Market Cap	122.89M
Enterprise Value	25.27M

Important Dates

The next estimated earnings date is Wednesday, March 18, 2026.

Earnings Date	Mar 18, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:BIOVIC.B has 291.91 million shares outstanding. The number of shares has increased by 74.32% in one year.

Current Share Class	277.49M
Shares Outstanding	291.91M
Shares Change (YoY)	+74.32%
Shares Change (QoQ)	+165.31%
Owned by Insiders (%)	8.58%
Owned by Institutions (%)	4.79%
Float	248.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.42
PB Ratio	0.99
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.33
EV / Sales	2.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.36

Financial Position

The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.02.

Current Ratio	8.28
Quick Ratio	8.11
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.59% and return on invested capital (ROIC) is -44.26%.

Return on Equity (ROE)	-72.59%
Return on Assets (ROA)	-39.53%
Return on Invested Capital (ROIC)	-44.26%
Return on Capital Employed (ROCE)	-62.28%
Revenue Per Employee	412,125
Profits Per Employee	-3.19M
Employee Count	27
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

In the past 12 months, STO:BIOVIC.B has paid 89,000 in taxes.

Income Tax	89,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.61% in the last 52 weeks. The beta is 1.27, so STO:BIOVIC.B's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-77.61%
50-Day Moving Average	0.49
200-Day Moving Average	0.65
Relative Strength Index (RSI)	44.92
Average Volume (20 Days)	724,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:BIOVIC.B had revenue of SEK 9.89 million and -76.47 million in losses. Loss per share was -0.55.

Revenue	9.89M
Gross Profit	9.99M
Operating Income	-78.11M
Pretax Income	-76.38M
Net Income	-76.47M
EBITDA	-77.25M
EBIT	-78.11M
Loss Per Share	-0.55

Balance Sheet

The company has 100.66 million in cash and 3.04 million in debt, with a net cash position of 97.63 million or 0.33 per share.

Cash & Cash Equivalents	100.66M
Total Debt	3.04M
Net Cash	97.63M
Net Cash Per Share	0.33
Equity (Book Value)	123.80M
Book Value Per Share	0.42
Working Capital	95.77M

Cash Flow

In the last 12 months, operating cash flow was -70.58 million and capital expenditures -434,000, giving a free cash flow of -71.01 million.

Operating Cash Flow	-70.58M
Capital Expenditures	-434,000
Free Cash Flow	-71.01M
FCF Per Share	-0.24

Margins

Gross Margin	100.96%
Operating Margin	-789.66%
Pretax Margin	-772.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:BIOVIC.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.32%
Shareholder Yield	-74.32%
Earnings Yield	-62.22%
FCF Yield	-57.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:BIOVIC.B has an Altman Z-Score of -1.1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.1
Piotroski F-Score	4